BJDX · Bluejay Diagnostics, Inc.
$1.07
-0.08 (-6.96%)
At close · Aug 7
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These financial results and financial position, and the Company's expected forward-looking outlook of significant negative cash flow in the future, raise substantial doubt with respect to its ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$1.19M
Shares
1.03M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$249.04K
FY2022
Net Income
-$6.85M
+11.3%
FY2025
Gross Margin
19.64%
FY2022
Operating Margin
-3741.48%
FY2022
Diluted EPS
-$15.25
+96.7%
FY2025
Operating Cash Flow
-$6.05M
+22.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| — | — | — | — | $249.04K | — | — | |
| — | — | — | — | — | -$367.46K | -$27K | |
| — | — | — | — | $200.13K | — | — | |
| — | — | — | — | $48.91K | — | — | |
| — | — | — | — | 19.64% | — | — | |
| $3.07M | $3.05M | $3.47M | $5.71M | $4.15M | $1.15M | $527.25K | |
| — | — | $8297 | $283.44K | $451.42K | $289.73K | $73.02K | |
| $3.93M | $3.91M | $3.69M | $4.31M | $4.76M | $1.79M | $596.12K | |
| — | — | — | $283.44K | $451.42K | — | — | |
| — | — | — | — | $156.6K | $145.72K | $157.04K | |
| $7M | $6.95M | $7.17M | $10.31M | $9.37M | $3.23M | $1.2M | |
| -$7M | -$6.95M | -$7.17M | -$10.31M | -$9.32M | -$3.23M | -$1.2M | |
| — | — | — | — | -3741.48% | — | — | |
| — | — | — | — | -$9.16M | -$3.08M | -$1.04M | |
| — | $839 | $823.03K | — | — | $6360 | — | |
| $98.62K | $97.56K | $145.82K | $164.9K | — | — | — | |
| $99.6K | $104.49K | -$548.18K | $357.33K | $20.83K | -$258.14K | $38.11K | |
| -$6.9M | -$6.85M | -$7.72M | -$9.95M | -$9.3M | -$3.49M | -$1.16M | |
| — | — | — | — | -3733.11% | — | — | |
| — | -$6.85M | -$20.94M | -$9.95M | — | — | — | |
| USD/shares | — | -$15.25 | -$456.75 | -$14,525.92 | -$14,752.00 | -$13,120.00 | — |
| USD/shares | — | -$15.25 | -$456.75 | -$14,525.92 | -$14,752.00 | -$13,120.00 | — |
| shares | — | 449.04K | 45.85K | 685.25 | 630.1225 | 266.3257 | 98.35 |
| shares | — | 449.04K | 45.85K | 685.25 | 630.1225 | 266.3257 | 98.35 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.88×
Peer medians compare against the 30 similar-size Medical Devices companies (of 145 listed).